Investment
 

Genovate Biotechnology Company Limited
Genovate Biotechnology Company Limited is a fully integrated specialty pharmaceutical company that focuses on new drug development, drug manufacturing, drug marketing and distribution in Taiwan and the region. Genovate has been listed on the Taiwan GreTai Securities Market (Open Market, stock code: 4130) since 12 January 2012. As of 31 December 2014, ENM Group held 6.3% shareholding in Genovate.

Please click here for further information of Genovate.

 
© ENM Holdings Limited.